Bioactivity:

EPZ5676 has been used in trials studying the treatment of Leukemia, Acute Leukemias, Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Acute Lymphocytic Leukemia, among others.

CAS nr:

1380288-87-8

Purity:

98%

Molecular Weight:

562,71

SMILES:

CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12)[C@@H]1C[C@H](CCc2nc3ccc(cc3[nH]2)C(C)(C)C)C1

Formula:

C30H42N8O3

Pathway:

Chromatin/Epigenetic

Target:

Histone Methyltransferase